Simcha Therapeutics (Series A)
Funding Details
- Awarder
- Inbox
- Date Award
- June 25, 2020
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
- Funding Amount:
- $25,000,000
Company Info
- Founding Year
- 2020
- Founders
- Aaron Ring, M.D., Ph.D.
- Company Description
- Simcha Therapeutics uses directed evolution to engineer novel cytokines designed to unlock the precision and power of the immune system. Simcha's lead program, ST-067, is a designer IL-18 cytokine that has shown potent antitumor effects in animal models, both as a monotherapy and when combined with anti-PD-1 checkpoint inhibitors.
- Market
- Immunotherapy
- Location
- New Haven, Connecticut, USA
- Coinvestors
- Connecticut Innovations, WuXi AppTec